Stay updated with breaking news from Survivorship Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 2b/3 study may proceed under U.S. Investigational New Drug applicationStudy design now accepted by U.S. and U.K. regulatory authoritiesAxcella to present at Long COVID forum co-sponsored by BIO and Solve M.E.Axcella to host a conference call February 16 at 8:00 a.m. ET; To register, click hereCAMBRIDGE, Mass.-...
A number of musicians and other entertainers have been severely debilitated as a result of long COVID.
Michael B. Harris, M.D., Professorship Established at Hackensack Meridian School of Medicine and The Children’s Cancer Institute Thanks to $1 Million Gift fro
Acclaimed oncologist and immunotherapy expert Neal Flomenberg, M.D. joins Tevogen Bio as Chief Scientific Officer (CSO) and Global Head of Research & DevelopmentDr. Flomenberg most recently served as Professor and Chairman of the Department of Medical Oncology and Deputy Director of Sidney Kimmel Cancer Center of Th...
Tevogen Bio appointed Dr. Neal Flomenberg as chief scientific officer and global head of research and development.